DTI-100

N/A

Report date: 2024/12/16 11:33:20
NME

Base Information

Drug NameDTI-100
Drug Alias NameDTI-100
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeurokinin 2 receptor agonists
TargetsNeurokinin 2 receptor
Therapy Area/IndicationsUrinary Bladder, NeurogenicGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDignify Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesDignify Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, NeurogenicGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A